Recurrent drug-induced ANCA vasculitis in a patient with Crohn's colitis treated with infliximab: a potential contraindication to immunosuppressive therapy

Am Surg. 2012 Dec;78(12):1406-8.

Authors

David R Rosen¹, Kyle G Cologne, Sarah M Popek, Brian C Sung, Adrian E Ortega, Anthony J Senagore

Affiliation

¹ Departments of General Colorectal Surgery, Keck Medical Center of the University of Southern California, Los Angeles, California, USA. david.rosen@med.usc.edu

PMID: 23265134

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / adverse effects
Adrenal Cortex Hormones / therapeutic use
Adult
Antibodies, Antineutrophil Cytoplasmic / immunology*
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Colectomy / methods
Contraindications
Crohn Disease / diagnosis
Crohn Disease / drug therapy*
Crohn Disease / surgery
Female
Follow-Up Studies
Gastrointestinal Agents / adverse effects
Gastrointestinal Agents / therapeutic use
Graves Disease / complications
Graves Disease / diagnosis
Graves Disease / drug therapy
Humans
Ileostomy / methods
Immunosuppressive Agents*
Infliximab
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / diagnosis
Lupus Erythematosus, Systemic / drug therapy
Recurrence
Risk Assessment
Severity of Illness Index
Treatment Outcome
Vasculitis / chemically induced*
Vasculitis / physiopathology

Substances

Adrenal Cortex Hormones
Antibodies, Antineutrophil Cytoplasmic
Antibodies, Monoclonal
Gastrointestinal Agents
Immunosuppressive Agents
Infliximab